Compass Pathways Plc ADR (CMPS)

$3.92 -0.01 (-0.25%)
Market Cap 333.08M
Revenue (ttm) 0.00
Net Income (ttm) -155.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.16
Volume 1,222,143
Avg Vol 2,823,362
Day's Range N/A - N/A
Shares Out 93.56M
Stochastic %K 97%
Beta 2.12
Analysts Strong Sell
Price Target $15.78

Company Profile

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incor...

Industry: Medical Care Facilities
Sector: Healthcare
Address:
33 Broadwick Street, London, United Kingdom
Stoneape
Stoneape Jul. 17 at 6:00 PM
$CMPS end of day run again?
0 · Reply
DougAfter60
DougAfter60 Jul. 17 at 5:59 PM
$CMPS took my profit 😎
1 · Reply
debbiekatz
debbiekatz Jul. 17 at 5:23 PM
$CMPS at 3.85. heading towards resistance around 4.2. will need to get thru to move towards 5. posted for team at 2.43 on 6/23 for 58% gain so far. this is a patient swing. posted in here at 3.4 for 13% gain so far.
0 · Reply
Tpeets101
Tpeets101 Jul. 17 at 5:19 PM
$CMPS 🚀 💰40 dollars EOY!
0 · Reply
zmanx
zmanx Jul. 17 at 4:53 PM
$CMPS green again off the news drop— mid $4 gap looks like it’ll fill
1 · Reply
twiggs462
twiggs462 Jul. 17 at 4:28 PM
$MNMD $ATAI $CMPS President Trump Signs HALT Fentanyl Act into Law https://www.whitehouse.gov/articles/2025/07/president-trump-signs-halt-fentanyl-act-into-law/
0 · Reply
twiggs462
twiggs462 Jul. 17 at 4:27 PM
$MNMD $ATAI $CMPS Trump Signs Fentanyl Criminalization Bill That Could Also Open Up Research On Marijuana, Psychedelics And Other Schedule I Drugs https://www.marijuanamoment.net/trump-signs-fentanyl-criminalization-bill-that-could-also-open-up-research-on-marijuana-psychedelics-and-other-schedule-i-drugs/
0 · Reply
PsychedStocks
PsychedStocks Jul. 17 at 3:51 PM
$CYBN $CMPS $ATAI $MNMD $GHRS Cybin Receives UK MHRA Approval to Commence EMBRACE, A Multinational Pivotal Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder https://ir.cybin.com/investors/news/news-details/2025/Cybin-Receives-UK-MHRA-Approval-to-Commence-EMBRACE-A-Multinational-Pivotal-Study-Evaluating-CYB003-for-the-Adjunctive-Treatment-of-Major-Depressive-Disorder/default.aspx
0 · Reply
PDTstockOwl
PDTstockOwl Jul. 17 at 3:09 PM
$CMPS love this
0 · Reply
CAVALRY_37748
CAVALRY_37748 Jul. 17 at 2:51 PM
$CMPS Just purchased 3 long CALL options. Price target 7.50 by Nov 21 2025.
1 · Reply
Latest News on CMPS
Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th, 8:00am ET

Jul 10, 2025, 4:00 PM EDT - 6 days ago

Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th, 8:00am ET

Compass Pathways Stock: Downgrading To Hold On Released TRD Results With COMP360

Jun 24, 2025, 2:47 PM EDT - 23 days ago

Compass Pathways Stock: Downgrading To Hold On Released TRD Results With COMP360

Vizsla Silver, COMPASS Pathways And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Jun 23, 2025, 8:25 AM EDT - 24 days ago

Vizsla Silver, COMPASS Pathways And Other Big Stocks Moving Lower In Monday's Pre-Market Session

VZLA

Compass Pathways stock slip as psilocybin depression trial falls short of expectations

Jun 23, 2025, 8:12 AM EDT - 24 days ago

Compass Pathways stock slip as psilocybin depression trial falls short of expectations

Compass Pathways' depression drug succeeds late-stage trial

Jun 23, 2025, 6:48 AM EDT - 24 days ago

Compass Pathways' depression drug succeeds late-stage trial

Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression

Jun 23, 2025, 6:30 AM EDT - 24 days ago

Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare Conference

May 14, 2025, 6:30 AM EDT - 2 months ago

Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare Conference

COMPASS Pathways plc (CMPS) Q1 2025 Earnings Call Transcript

May 8, 2025, 11:14 AM EDT - 2 months ago

COMPASS Pathways plc (CMPS) Q1 2025 Earnings Call Transcript

Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights

May 8, 2025, 6:30 AM EDT - 2 months ago

Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights

Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities

Apr 29, 2025, 6:30 AM EDT - 2 months ago

Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities

Compass Pathways to Announce First Quarter Financial Results on May 8, 2025

Apr 28, 2025, 6:30 AM EDT - 2 months ago

Compass Pathways to Announce First Quarter Financial Results on May 8, 2025

Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Apr 22, 2025, 6:00 AM EDT - 3 months ago

Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

This Is a Test From GlobeNewswire

Mar 28, 2025, 5:01 PM EDT - 3 months ago

This Is a Test From GlobeNewswire

ALVO

Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Mar 26, 2025, 6:30 AM EDT - 4 months ago

Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression

Mar 18, 2025, 6:30 AM EDT - 4 months ago

Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways to Participate in Stifel Virtual CNS Forum

Mar 11, 2025, 6:30 AM EDT - 4 months ago

Compass Pathways to Participate in Stifel Virtual CNS Forum

Compass Pathways: Betting On The Future Of Psilocybin Therapy

Feb 28, 2025, 5:08 PM EST - 4 months ago

Compass Pathways: Betting On The Future Of Psilocybin Therapy

Psychedelics-Focused Compass Pathways Has Established Itself As 'Credible CNS Biotechnology Company,' Analyst Says

Feb 27, 2025, 4:02 PM EST - 4 months ago

Psychedelics-Focused Compass Pathways Has Established Itself As 'Credible CNS Biotechnology Company,' Analyst Says

COMPASS Pathways plc (CMPS) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 10:41 AM EST - 5 months ago

COMPASS Pathways plc (CMPS) Q4 2024 Earnings Call Transcript

Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights

Feb 27, 2025, 6:30 AM EST - 5 months ago

Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights

Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference

Feb 25, 2025, 4:00 PM EST - 5 months ago

Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Feb 18, 2025, 6:30 AM EST - 5 months ago

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

Feb 5, 2025, 6:30 AM EST - 5 months ago

Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer

Jan 21, 2025, 6:30 AM EST - 6 months ago

Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer

Compass Pathways Announces Pricing of Underwritten Offering

Jan 10, 2025, 7:01 AM EST - 6 months ago

Compass Pathways Announces Pricing of Underwritten Offering

Compass Pathways to Be Added to the NASDAQ Biotechnology Index (NBI)

Dec 18, 2024, 6:30 AM EST - 7 months ago

Compass Pathways to Be Added to the NASDAQ Biotechnology Index (NBI)

Compass Pathways to Participate in December Investor Conferences

Nov 25, 2024, 4:00 PM EST - 8 months ago

Compass Pathways to Participate in December Investor Conferences

Compass Pathways to participate in Stifel 2024 Healthcare Conference

Nov 14, 2024, 7:44 AM EST - 8 months ago

Compass Pathways to participate in Stifel 2024 Healthcare Conference

Top 3 Health Care Stocks You'll Regret Missing In November

Nov 5, 2024, 6:58 AM EST - 9 months ago

Top 3 Health Care Stocks You'll Regret Missing In November

PACS SGHT

Compass Pathways: Minor Delay Of COMP360 Data Brings About Buy Opportunity

Nov 1, 2024, 5:10 PM EDT - 9 months ago

Compass Pathways: Minor Delay Of COMP360 Data Brings About Buy Opportunity

COMPASS Pathways plc (CMPS) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 2:49 PM EDT - 9 months ago

COMPASS Pathways plc (CMPS) Q3 2024 Earnings Call Transcript

Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates

Oct 31, 2024, 6:30 AM EDT - 9 months ago

Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates

Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024

Oct 24, 2024, 6:30 AM EDT - 9 months ago

Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024

Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit

Sep 23, 2024, 7:00 AM EDT - 10 months ago

Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit

Compass Pathways to participate in three investor conferences in September

Aug 28, 2024, 6:00 AM EDT - 11 months ago

Compass Pathways to participate in three investor conferences in September

Psychedelic Stocks: Focus On Their Cash

Aug 15, 2024, 12:30 PM EDT - 1 year ago

Psychedelic Stocks: Focus On Their Cash

MNMD

Psychedelic drug contender stocks drop after FDA rejects MDMA treatment

Aug 12, 2024, 12:12 PM EDT - 1 year ago

Psychedelic drug contender stocks drop after FDA rejects MDMA treatment

ATAI CYBN MNMD

COMPASS Pathways plc (CMPS) Q2 2024 Earnings Call Transcript

Aug 4, 2024, 1:22 AM EDT - 1 year ago

COMPASS Pathways plc (CMPS) Q2 2024 Earnings Call Transcript

Compass Pathways announces second quarter 2024 financial results and business highlights

Aug 1, 2024, 6:30 AM EDT - 1 year ago

Compass Pathways announces second quarter 2024 financial results and business highlights

Compass Pathways to announce second quarter financial results on August 1, 2024

Jul 24, 2024, 7:01 AM EDT - 1 year ago

Compass Pathways to announce second quarter financial results on August 1, 2024

Compass Pathways: Buy It For Its Promising Psychedelic Mental Health Therapies

Jul 8, 2024, 10:11 AM EDT - 1 year ago

Compass Pathways: Buy It For Its Promising Psychedelic Mental Health Therapies

Compass Pathways appoints Lori Englebert as Chief Commercial Officer

Jun 26, 2024, 6:30 AM EDT - 1 year ago

Compass Pathways appoints Lori Englebert as Chief Commercial Officer

Compass Pathways to participate in upcoming H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

Jun 24, 2024, 4:01 PM EDT - 1 year ago

Compass Pathways to participate in upcoming H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

Psychedelics Closer To Commercialization; Compass Far And Away The Leader

May 23, 2024, 12:15 PM EDT - 1 year ago

Psychedelics Closer To Commercialization; Compass Far And Away The Leader

MNMD

COMPASS Pathways plc (CMPS) Q1 2024 Earnings Call Transcript

May 11, 2024, 5:31 PM EDT - 1 year ago

COMPASS Pathways plc (CMPS) Q1 2024 Earnings Call Transcript

Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights

May 8, 2024, 6:45 AM EDT - 1 year ago

Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights

Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder

May 8, 2024, 6:30 AM EDT - 1 year ago

Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder

Compass Pathways to announce first quarter financial results on May 8, 2024

May 3, 2024, 4:58 PM EDT - 1 year ago

Compass Pathways to announce first quarter financial results on May 8, 2024

Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment

May 2, 2024, 6:30 AM EDT - 1 year ago

Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment

Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression

Apr 29, 2024, 6:30 AM EDT - 1 year ago

Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression

Stoneape
Stoneape Jul. 17 at 6:00 PM
$CMPS end of day run again?
0 · Reply
DougAfter60
DougAfter60 Jul. 17 at 5:59 PM
$CMPS took my profit 😎
1 · Reply
debbiekatz
debbiekatz Jul. 17 at 5:23 PM
$CMPS at 3.85. heading towards resistance around 4.2. will need to get thru to move towards 5. posted for team at 2.43 on 6/23 for 58% gain so far. this is a patient swing. posted in here at 3.4 for 13% gain so far.
0 · Reply
Tpeets101
Tpeets101 Jul. 17 at 5:19 PM
$CMPS 🚀 💰40 dollars EOY!
0 · Reply
zmanx
zmanx Jul. 17 at 4:53 PM
$CMPS green again off the news drop— mid $4 gap looks like it’ll fill
1 · Reply
twiggs462
twiggs462 Jul. 17 at 4:28 PM
$MNMD $ATAI $CMPS President Trump Signs HALT Fentanyl Act into Law https://www.whitehouse.gov/articles/2025/07/president-trump-signs-halt-fentanyl-act-into-law/
0 · Reply
twiggs462
twiggs462 Jul. 17 at 4:27 PM
$MNMD $ATAI $CMPS Trump Signs Fentanyl Criminalization Bill That Could Also Open Up Research On Marijuana, Psychedelics And Other Schedule I Drugs https://www.marijuanamoment.net/trump-signs-fentanyl-criminalization-bill-that-could-also-open-up-research-on-marijuana-psychedelics-and-other-schedule-i-drugs/
0 · Reply
PsychedStocks
PsychedStocks Jul. 17 at 3:51 PM
$CYBN $CMPS $ATAI $MNMD $GHRS Cybin Receives UK MHRA Approval to Commence EMBRACE, A Multinational Pivotal Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder https://ir.cybin.com/investors/news/news-details/2025/Cybin-Receives-UK-MHRA-Approval-to-Commence-EMBRACE-A-Multinational-Pivotal-Study-Evaluating-CYB003-for-the-Adjunctive-Treatment-of-Major-Depressive-Disorder/default.aspx
0 · Reply
PDTstockOwl
PDTstockOwl Jul. 17 at 3:09 PM
$CMPS love this
0 · Reply
CAVALRY_37748
CAVALRY_37748 Jul. 17 at 2:51 PM
$CMPS Just purchased 3 long CALL options. Price target 7.50 by Nov 21 2025.
1 · Reply
Stoneape
Stoneape Jul. 17 at 2:28 PM
$CMPS psychological wall at $4 it will pierce through shortly
0 · Reply
doctoriv
doctoriv Jul. 17 at 11:58 AM
$CMPS early exit at 3.80 yesterday, Just wanted to lock the profit. Good luck ladies and gents!
3 · Reply
Bulltrader988
Bulltrader988 Jul. 17 at 1:57 AM
$CMPS ... 👃👀
0 · Reply
BioBum
BioBum Jul. 16 at 10:43 PM
$CMPS market cap should be at least 500MM
0 · Reply
Mjcwo
Mjcwo Jul. 16 at 9:11 PM
$CMPS Cathie’s buying more….so am I.
1 · Reply
Momabeat
Momabeat Jul. 16 at 9:08 PM
$CMPS nice gains today! Just getting started!
0 · Reply
Stoneape
Stoneape Jul. 16 at 8:42 PM
$CMPS I know it’s a long ways away but if this passes $5 on the way up who knows where this lands
0 · Reply
FBP
FBP Jul. 16 at 8:19 PM
$CMPS incredibly recovery
1 · Reply
brodobagginz
brodobagginz Jul. 16 at 7:52 PM
$CMPS well, it would appear ms. cathie still has some clout on the street - not sure today is a coincidence w the form 4 she just filed (which was only one of several recent buys that crossed the form 4 threshold).
2 · Reply
Luffy1495
Luffy1495 Jul. 16 at 7:50 PM
$CMPS such a dumb sell off on the very positive phase 3 news. Was painful to stick it out, but I’ve been here awhile so I remained unfazed. I see nothing but positive headwinds for us going forward.
2 · Reply
_www_larval_com_
_www_larval_com_ Jul. 16 at 7:48 PM
$CMPS just soared 5% higher to 9% (~2Mv) moments ago, 07/18 options, follow for more volatility.
0 · Reply
LIVE_Trading
LIVE_Trading Jul. 16 at 6:53 PM
$IONQ $CMPS Could see nHod $SPY $QQQ $NVDA
0 · Reply